Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Updated Guidance To Address New Humanitarian Device Exemption Provisions

This article was originally published in The Gray Sheet

Executive Summary

FDA plans on issuing updated guidance on humanitarian device exemptions "soon" to reflect provisions in the FDA Amendments Act of 2007, says Debra Lewis, associate director of the agency's Office of Orphan Products Development

You may also be interested in...



Guidance: How To Profit From Humanitarian-Use Devices In Pediatric Patients

1Draft guidance issued Aug. 5 clarifies FDA's new policy for allowing companies to profit from humanitarian-use devices in pediatric populations

Guidance: How To Profit From Humanitarian-Use Devices In Pediatric Patients

1Draft guidance issued Aug. 5 clarifies FDA's new policy for allowing companies to profit from humanitarian-use devices in pediatric populations

Pediatric Device Developers Counting On Easier Path To Market

Developing medical technologies exclusively for children has not typically been an easy or profitable path to tread

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel